NCT00745771View on ClinicalTrials.gov

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

November 30, 2008

Conditions
Muscle Soreness
Interventions
DRUG

Diractin

DRUG

Diractin

Trial Locations (1)

07745

X-pert Med GmbH, Jena

Sponsors

Lead Sponsor

IDEA AG
All Listed Sponsors
lead

IDEA AG

INDUSTRY

NCT00745771 - Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness | Biotech Hunter | Biotech Hunter